Is Disc Medicine, Inc. (IRON) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 1.3% / 30% | 33.9% / 30% | 0.0% / 30% | N/A | ✗ NOT HALAL |
| DJIM | 1.3% / 33% | 33.9% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| MSCI | 3.8% / 33% | 98.1% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| S&P | 1.3% / 33% | 33.9% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| FTSE | 3.8% / 33% | 98.1% / 33% | 0.0% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -35.9% | |
| Return on Assets (ROA) | -22.5% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$180M |
| Free Cash Flow | -$181M |
| Total Debt | $31M |
| Debt-to-Equity | 4.2 |
| Current Ratio | 21.9 |
| Total Assets | $807M |
Price & Trading
| Last Close | $62.01 |
| 50-Day MA | $68.07 |
| 200-Day MA | $70.03 |
| Avg Volume | 700K |
| Beta | 2.7 |
|
52-Week Range
$30.82
| |
About Disc Medicine, Inc. (IRON)
Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. It also develops preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. The company was founded in 2017 and is headquartered in Watertown, Massachusetts.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Disc Medicine, Inc. (IRON) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Disc Medicine, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Disc Medicine, Inc.'s debt ratio?
Disc Medicine, Inc.'s debt ratio is 1.3% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 3.8%.
What are Disc Medicine, Inc.'s key financial metrics?
Disc Medicine, Inc. has a market capitalization of $2.3B. Return on equity stands at -35.9%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.